BioSig Technologies, Inc.

8441 Wayzata Blvd., Suite 240

Minneapolis, Minnesota 55426

September 20, 2017

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance
Securities and Exchange Commission
Washington, D.C. 20549

Attention: Amanda Ravitz

Re: BioSig Technologies, Inc.

Registration Statement on Form S-1, originally filed on June 8, 2017

File No. 333- 218583, as amended (the “Registration Statement”)

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioSig Technologies, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 5:00 p.m., Eastern Time, on September 21, 2017, or as soon thereafter as practicable.

	Very truly yours, BIOSIG TECHNOLOGIES, INC.

	By:	/s/ Kenneth Londoner
		Kenneth Londoner Chief Executive Officer

cc: Rick A. Werner, Esq., Haynes and Boone, LLP